US9447087, 105

ID: ALA3932976

PubChem CID: 46926071

Max Phase: Preclinical

Molecular Formula: C18H18ClN7O2

Molecular Weight: 399.84

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CNC(=O)C1=C(C)NC(Nc2nc3ccccc3o2)=NC1c1nn(C)cc1Cl

Standard InChI:  InChI=1S/C18H18ClN7O2/c1-9-13(16(27)20-2)15(14-10(19)8-26(3)25-14)23-17(21-9)24-18-22-11-6-4-5-7-12(11)28-18/h4-8,15H,1-3H3,(H,20,27)(H2,21,22,23,24)

Standard InChI Key:  LJYIEDZBEIDLQF-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 28 31  0  0  0  0  0  0  0  0999 V2000
   -2.5759  -10.6381    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9701   -9.6022    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4693   -9.6095    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1253  -10.6519    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.2883   -8.3139    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7883   -8.3192    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3847   -9.3605    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5428   -7.0227    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7974   -5.7210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2973   -5.7159    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4572   -7.0123    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9579   -7.0071    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8201   -8.2190    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2458   -7.7528    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2179   -8.4563    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2429   -6.2528    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8155   -5.7919    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4357   -4.6536    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    2.5497   -4.4224    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.8032   -3.1233    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4133   -1.7530    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.2990   -0.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2990    0.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    1.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2990    0.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2990   -0.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -1.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3114   -2.9665    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  2  0
  6  7  1  0
  6  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11  5  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 14 16  1  0
 16 17  2  0
 17 12  1  0
 17 18  1  0
  9 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
 27 28  1  0
 28 20  2  0
M  END

Associated Targets(Human)

GALK1 Tbio Galactokinase (959 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 399.84Molecular Weight (Monoisotopic): 399.1211AlogP: 2.35#Rotatable Bonds: 3
Polar Surface Area: 109.37Molecular Species: NEUTRALHBA: 8HBD: 3
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 10.11CX Basic pKa: 4.81CX LogP: 1.58CX LogD: 1.58
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.62Np Likeness Score: -1.24

References

1.  (2016)  Galactokinase inhibitors for the treatment and prevention of associated diseases and disorders, 
2.  (2019)  Galactokinase inhibitors for the treatment and prevention of associated diseases and disorders,